NANS Joins Multi-Society Comments on Proposed BVN Coverage Policy

The North American Neuromodulation Society (NANS), alongside leading national pain and spine organizations, has submitted a joint comment letter to National Government Services (NGS) regarding its proposed Local Coverage Determination (LCD) for thermal destruction of the intraosseous basivertebral nerve (BVN) to treat vertebrogenic low back pain.

​NANS supports coverage of basivertebral nerve ablation (BVNA) and commends NGS for advancing access to this therapy for Medicare beneficiaries. In the letter, the societies recommend targeted refinements to ensure the policy reflects current evidence, supports appropriate patient selection, and avoids unintended barriers to care.
 
Key areas addressed include clarification around psychological screening requirements, flexibility in imaging interpretation and Modic change documentation, thoughtful application of imaging-based exclusion criteria, and updated considerations regarding osteoporosis and radicular pain exclusions.
 
This letter is part of NANS’ ongoing advocacy efforts to promote fair, evidence-based coverage policies that support both clinicians and patients.

READ FULL LETTER